(RTTNews) - SK bioscience Co. (302440.KS) reported a first quarter net loss attributable to shareholders of parent company of 33.3 billion korean won compared to a loss of 7.5 billion won, last year. Operating loss widened to 44.5 billion won compared to a loss of 15.1 billion wo
(RTTNews) - SK bioscience Co. (302440.KS) reported a first quarter net loss attributable to shareholders of parent company of 33.3 billion korean won compared to a loss of 7.5 billion won, last year. Operating loss widened to 44.5 billion won compared to a loss of 15.1 billion wo
Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.
Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.
Earnings Call Insights: Crexendo (CXDO) Q1 2026 Management view "This really was a very special quarter for us" as "Revenue for the quarter was $20.7 million, up 29% year-over-year" and "We delivered GAAP net income of $0.6 million and non-GAAP income of $3.3 million," according to (CEO & Executive Chairman Jeffrey Korn). "The ESI acquisition is exceeding our expectations and is already contributi...
Earnings Call Insights: Crexendo (CXDO) Q1 2026 Management view "This really was a very special quarter for us" as "Revenue for the quarter was $20.7 million, up 29% year-over-year" and "We delivered GAAP net income of $0.6 million and non-GAAP income of $3.3 million," according to (CEO & Executive Chairman Jeffrey Korn). "The ESI acquisition is exceeding our expectations and is already contributing meaningfully across the income statement" and "Integration is advancing ahead of plan across sales, operations, engineering," (CEO & Executive Chairman Korn) said. "We just secured $5 million in term debt along with a line of credit" and "We didn't borrow the money because we need it" but "to secure future acquisitions," (CEO & Executive Chairman Korn) said, adding, "We do not anticipate deploying this capital in the immediate quarter or 2." "Organic growth for that quarter was 15.9% over the prior year quarter" and "we completed our debt financing credit facility with Wells Fargo Bank for a $5 million term loan and a $5 million revolving credit facility," (Chief Financial Officer Ron Vincent) said. "The stronger demand for all of our offerings continues, and we are seeing strong traction with our new AI applications, including our recently released Crexendo AI receptionist orchestrator that we refer to as CAIRO," (COO & President Doug Gaylor) said. Outlook Analysts’ estimates were provided, but the format uses numeric quarters (e.g., 1, 2, 3, 4) rather than Q1–Q4, so the estimates were treated as invalid and excluded from comparisons. "Looking ahead, we remain confident in our ability to deliver sustained double-digit organic growth" and "While macro conditions may continue to impact timing on larger enterprise decisions, underlying demand remains strong and our pipeline supports continued momentum," (CEO & Executive Chairman Korn) said. "No. By organic, I meant excluding ESI" and "I am guiding toward double-digit organic growth of the business outside of ESI," (CEO & E...
traffic_analyzer/iStock via Getty Images The S&P Global Spain Composite PMI recorded 48.7 in April, down from 52.4 last month. The decline in activity was, however, driven by the services economy as manufacturing output rose solidly. The S&P Global Spain Manufacturing PMI rose to 51.7 in April 2026 from 48.7 in March, surpassing market forecasts of 49.5. The service sector falls into contraction t...
traffic_analyzer/iStock via Getty Images The S&P Global Spain Composite PMI recorded 48.7 in April, down from 52.4 last month. The decline in activity was, however, driven by the services economy as manufacturing output rose solidly. The S&P Global Spain Manufacturing PMI rose to 51.7 in April 2026 from 48.7 in March, surpassing market forecasts of 49.5. The service sector falls into contraction territory as uncertainty weighs on demand. “Unlike the somewhat surprisingly decent manufacturing sector performance—although admittedly here growth was driven by client stockpiling as part of efforts to secure goods on fears of product shortages and supply disruption—the downbeat April PMI figures for services were somewhat less unexpected in the context of the knock to confidence that the war in the Middle East has caused,” said Paul Smith, economics director at S&P Global Market Intelligence. More on Spain EWP: Expect A Slow Tourism Season Amid Surging Fuel Costs And Weak Consumer Sentiments EWP: Spain Steadies Itself After A March Correction, Low-Teens P/E EUFN: A Maturing Rally With Room To Run Spain's service sector growth sustained in March Spain shuts airspace for U.S. planes involved in Iran attacks
FREDERICA ABAN/iStock via Getty Images 5-Year Morningstar Rating™ Class A Institutional Class The Morningstar Rating is for the indicated share classes only as of 03/31/26; other classes may have different performance characteristics. The Morningstar ratings for the overall, three-, five- and ten-year periods for Class A shares are 3 stars, 3 stars, 4 stars and 3 stars and for Institutional Class ...
FREDERICA ABAN/iStock via Getty Images 5-Year Morningstar Rating™ Class A Institutional Class The Morningstar Rating is for the indicated share classes only as of 03/31/26; other classes may have different performance characteristics. The Morningstar ratings for the overall, three-, five- and ten-year periods for Class A shares are 3 stars, 3 stars, 4 stars and 3 stars and for Institutional Class shares are 3 stars, 3 stars, 4 stars and 3 stars among 1048, 1048, 983 and 823 Large Value funds, respectively, and are based on a Morningstar Risk-Adjusted Return measure. Fund strategy Invests in companies that have historically paid consistent and increasing dividends Diversifies broadly with stocks representing dividend-paying sectors, including non-traditional ones such as technology, basic materials and consumer discretionary Incorporates our extensive research capabilities to find companies with healthy balance sheets and potential for high income and total return Expense ratio Share class No waiver (gross) With waiver (net) Institutional 0.78% 0.78% A 1.03% 1.03% Click to enlarge From the fund's most recent prospectus. Net expense ratio reflects a contractual fee waiver/expense reimbursement through 09/30/2026, unless sooner terminated at the sole discretion of the fund's board. Fund performance Columbia Dividend Opportunity Fund Institutional Class ( CDOZX ) shares returned 5.23% for the three months ended March 31, 2026. The fund strongly outperformed the 2.10% return of its benchmark, the Russell 1000 Value Index – Net. For monthly performance information, please check online at columbiathreadneedleus.com . Market overview The U.S. equity market produced uneven returns with elevated volatility during the first quarter. The first two months of the year were generally positive, with expectations for continued economic growth and falling interest rates providing firm support for risk assets. This favorable backdrop changed considerably in March with the onset of the...